(19)
(11) EP 1 070 503 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
14.09.2005 Bulletin 2005/37

(45) Mention of the grant of the patent:
15.06.2005 Bulletin 2005/24

(21) Application number: 99500184.9

(22) Date of filing: 13.10.1999
(51) International Patent Classification (IPC)7: A61K 31/715, A61P 9/00, A61P 9/14

(54)

Compositions comprising low molecular weight Heparin

Zusammensetzungen enthaltend Heparin mit niedrigem Molekülargewicht

Compositions contenant de l'héparin à bas poids moleculaire

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30) Priority: 23.07.1999 ES 9901671

(43) Date of publication of application:
24.01.2001 Bulletin 2001/04

(73) Proprietor: LABORATORIOS FARMACEUTICOS ROVI, S.A.
28037 Madrid (ES)

(72) Inventor:
  • Mardiguian, Jean
    94210 La Varenne (FR)

(74) Representative: Davila Baz, Angel 
c/o Clarke, Modet & Co., Goya, 11
28001 Madrid
28001 Madrid (ES)


(56) References cited: : 
EP-A- 0 133 078
WO-A-98/55515
US-A- 5 576 304
 EP-A- 0 293 539
US-A- 4 981 955
   
  • CHOAY, J. ET AL.: "Structural Studies on a Biologically Active Hexasaccharides obtained from Heparin" ANNALS NEW YORK ACADEMY OF SCIENCES, vol. 370, 1981, pages 644-649, XP000918149
  • DATABASE WPI Week 199408 Derwent Publications Ltd., London, GB; AN 1994062063 XP002146575 "New Tetrasaccharides: Useful as Anticoagulants" (SEIKAGAKU KOGYO CO LTD.), 3 July 1992 (1992-07-03) & PATENT ABSTRACTS OF JAPAN vol. 018, no. 222, 21 April 1994 (1994-04-21) & JP 06 016687 A (SEIKAGAKU KOGYO CO LTD), 25 January 1994 (1994-01-25)
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).